This project will characterize the physiological effect of the hormones, GIP-, GLP-1- and GLP-2 infusions in a group of individuals that are carriers of GIP-, GLP-1- and GLP-2 receptor gene variants, respectively.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
For GIP- and GLP-1 receptor variants: Insulinotropic effect (C-peptide)
Timeframe: 240 minutes
For GLP-2 receptor variants: CTX (bone resorption marker)
Timeframe: 120 minutes